iBio is a biotechnology company and biologics contract development and manufacturing organization (CDMO). It develops products to treat fibrotic diseases, cancers, and infectious diseases. iBio's platforms and programs include CDMO services using its FastPharming technologies and glycaneering services; the development of therapeutics and vaccines, for which iBio conducts preclinical and clinical trials, and the production of proteins for research and further manufacturing use in 3D-bioprinting and other applications.